Log in
Enquire now
Datar Cancer Genetics

Datar Cancer Genetics

Datar Cancer Genetics is a Nashik-based company developing non-invasive cancer diagnostics founded in 1992.

OverviewStructured DataIssuesContributors

Contents

datarpgx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biology
Biology
Biopsy
Biopsy
Medical diagnostics
Medical diagnostics
Biomedical engineering
Biomedical engineering
Molecular biology
Molecular biology
Molecular diagnostics
Molecular diagnostics
Technology
Technology
Biotechnology
Biotechnology
...
Location
Maharashtra
Maharashtra
Surrey
Surrey
Democratic Republic of the Congo
Democratic Republic of the Congo
Eckersdorf
Eckersdorf
Nashik
Nashik
B2X
B2B
B2B
0
CEO
‌
Rajan Datar
Pitchbook URL
pitchbook.com/profiles.../65407-42
Date Incorporated
2014
Number of Employees (Ranges)
51 – 200
Email Address
Phone Number
Full Address
Surrey Technology Centre, 4 Frederick Sanger Road, The, Guildford GU2 7YD
Schwester-Marie-Weg 11, 95488 Eckersdorf
F-8 AMBAD, Maharashtra 422010
Investors
Brand Capital
Brand Capital
Founded Date
1992
Latest Funding Round Date
March 1, 2014
Competitors
Tempus Labs (company)
Tempus Labs (company)
Country
Germany
Germany
United Kingdom
United Kingdom
India
India

Other attributes

Company Operating Status
Active
Public/Private
Private
Wikidata ID
Q77081246
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Datar Cancer Genetics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.